Folgen
Laura M. Shelton
Laura M. Shelton
bitBiome
Bestätigte E-Mail-Adresse bei bitbiome.bio
Titel
Zitiert von
Zitiert von
Jahr
Cancer as a metabolic disease
TN Seyfried, LM Shelton
Nutrition & metabolism 7, 1-22, 2010
8542010
SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance
D Kim, BP Fiske, K Birsoy, E Freinkman, K Kami, RL Possemato, ...
Nature 520 (7547), 363-367, 2015
3522015
Differential glutamate metabolism in proliferating and quiescent mammary epithelial cells
JL Coloff, JP Murphy, CR Braun, IS Harris, LM Shelton, K Kami, SP Gygi, ...
Cell metabolism 23 (5), 867-880, 2016
2632016
PHGDH expression is required for mitochondrial redox homeostasis, breast cancer stem cell maintenance, and lung metastasis
D Samanta, Y Park, SA Andrabi, LM Shelton, DM Gilkes, GL Semenza
Cancer research 76 (15), 4430-4442, 2016
2242016
Metabolic management of brain cancer
TN Seyfried, MA Kiebish, J Marsh, LM Shelton, LC Huysentruyt, ...
Biochimica et Biophysica Acta (BBA)-Bioenergetics 1807 (6), 577-594, 2011
1852011
Arginine deprivation inhibits the Warburg effect and upregulates glutamine anaplerosis and serine biosynthesis in ASS1-deficient cancers
JC Kremer, BC Prudner, SES Lange, GR Bean, MB Schultze, ...
Cell reports 18 (4), 991-1004, 2017
1292017
Glutamine targeting inhibits systemic metastasis in the VM‐M3 murine tumor model
LM Shelton, LC Huysentruyt, TN Seyfried
International Journal of Cancer 127 (10), 2478-2485, 2010
1162010
Metastatic cancer cells with macrophage properties: evidence from a new murine tumor model
LC Huysentruyt, P Mukherjee, D Banerjee, LM Shelton, TN Seyfried
International journal of cancer 123 (1), 73-84, 2008
952008
Is the restricted ketogenic diet a viable alternative to the standard of care for managing malignant brain cancer?
TN Seyfried, J Marsh, LM Shelton, LC Huysentruyt, P Mukherjee
Epilepsy research 100 (3), 310-326, 2012
942012
Calorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse
LM Shelton, LC Huysentruyt, P Mukherjee, TN Seyfried
ASN neuro 2 (3), AN20100002, 2010
772010
A novel pre-clinical in vivo mouse model for malignant brain tumor growth and invasion
LM Shelton, P Mukherjee, LC Huysentruyt, I Urits, JA Rosenberg, ...
Journal of neuro-oncology 99, 165-176, 2010
662010
Does the existing standard of care increase glioblastoma energy metabolism?
TN Seyfried, LM Shelton, P Mukherjee
The lancet oncology 11 (9), 811-813, 2010
602010
Thematic review series: sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a
P Mukherjee, AC Faber, LM Shelton, RC Baek, TC Chiles, TN Seyfried
Journal of lipid research 49 (5), 929-938, 2008
602008
MUC1* ligand, NM23-H1, is a novel growth factor that maintains human stem cells in a more naive state
BJ Smagghe, AK Stewart, MG Carter, LM Shelton, KJ Bernier, EJ Hartman, ...
PloS one 8 (3), e58601, 2013
492013
Provocative question: should ketogenic metabolic therapy become the standard of care for glioblastoma?
TN Seyfried, L Shelton, G Arismendi-Morillo, M Kalamian, A Elsakka, ...
Neurochemical research 44, 2392-2404, 2019
452019
Influence of methotrexate and cisplatin on tumor progression and survival in the VM mouse model of systemic metastatic cancer
LC Huysentruyt, LM Shelton, TN Seyfried
International journal of cancer 126 (1), 65-72, 2010
362010
Quantification of folate metabolism using transient metabolic flux analysis
PM Tedeschi, N Johnson-Farley, H Lin, LM Shelton, T Ooga, G Mackay, ...
Cancer & metabolism 3 (1), 1-14, 2015
232015
Ganglioside GM3 suppresses the pro-angiogenic effects of vascular endothelial growth factor and ganglioside GD1A
P Mukherjee, AC Faber, LM Shelton, RC Baek, TC Chiles, TN Seyfried
J Lipid Res 49 (5), 929-938, 2008
232008
Mycoplasma infection and hypoxia initiate succinate accumulation and release in the VM-M3 cancer cells
RE Flores, AK Brown, L Taus, J Khoury, F Glover, K Kami, ...
Biochimica et Biophysica Acta (BBA)-Bioenergetics 1859 (9), 975-983, 2018
192018
Targeting pheochromocytoma/paraganglioma with polyamine inhibitors
SK Rai, F Bril, HM Hatch, Y Xu, L Shelton, S Kalavalapalli, A Click, D Lee, ...
Metabolism 110, 154297, 2020
102020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20